Legend Biotech Corporation
Legend Biotech Corporation (LEGN) Stock Overview
Explore Legend Biotech Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.2B
P/E Ratio
-10.91
EPS (TTM)
$-1.61
ROE
-0.29%
LEGN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Legend Biotech Corporation (LEGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.47.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.91 and a market capitalization of 3.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.